Article metrics

Download PDFPDF

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: August 2017 to July 2019

AbstractFullPdf
Aug 2017015744
Sep 2017012772
Oct 2017010040
Nov 2017011138
Dec 2017017468
Jan 2018011935
Feb 2018313349
Mar 2018168327
Apr 2018858416
May 2018787826
Jun 201810010021
Jul 2018666553
Aug 2018767515
Sep 2018646439
Oct 2018858625
Nov 2018686630
Dec 2018787815
Jan 2019909131
Feb 2019756923
Mar 2019847921
Apr 2019736816
May 2019666624
Jun 2019837927
Jul 201913113332
Total13212285787